# Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

> **NCT01093131** · PHASE4 · WITHDRAWN · sponsor: **The Western Pennsylvania Hospital**

## Conditions studied

- Contrast Induced Nephropathy

## Interventions

- **OTHER:** Oral hydration
- **DRUG:** Oral sodium bicarbonate
- **OTHER:** Intravenous Hydration
- **DRUG:** Intravenous sodium bicarbonate

## Key facts

- **NCT ID:** NCT01093131
- **Lead sponsor:** The Western Pennsylvania Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-02
- **Primary completion:** 2009-09
- **Final completion:** 2010-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator left institution
- **Last updated:** 2019-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093131, "Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01093131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*